Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (181-190 of 287) with videos related to

Pageof 29
Sort By:
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
European Urology|May 1, 2012
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trialAndrew Vickers, Caroline Bennette, Gunnar Steineck, et al.
International Journal of Cancer|June 4, 2017
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohortPaul Nderitu, Cecilia Bosco, Hans Garmo, et al.
European Journal of Pediatrics|December 26, 2006
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraMinola Manea, AnnCharlotte Kristoffersson, Han-Mou Tsai, et al.
Cancer Causes & Control : CCC|June 10, 2010
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyMieke Van Hemelrijck, Hans Garmo, Elisa Binda, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2011
Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosisHenrik Møller, Fredrik Sandin, David Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2017
Breast cancer in young women and prognosis: How important are proliferation markers?Hanna Fredholm, Kristina Magnusson, Linda S Lindström, et al.
Scandinavian Journal of Urology|March 8, 2021
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancerJohannes Bobjer, Oskar Hagberg, Firas Aljabery, et al.
BJUI Compass|May 7, 2025
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer: A nationwide population-based cohort studyChristel Häggström, Oskar Hagberg, Lars Holmberg, et al.
Pageof 29

Showing results (181-190 of 287) with videos related to

Sort By:
Pageof 29
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
European Urology|May 1, 2012
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trialAndrew Vickers, Caroline Bennette, Gunnar Steineck, et al.
International Journal of Cancer|June 4, 2017
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohortPaul Nderitu, Cecilia Bosco, Hans Garmo, et al.
European Journal of Pediatrics|December 26, 2006
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraMinola Manea, AnnCharlotte Kristoffersson, Han-Mou Tsai, et al.
Cancer Causes & Control : CCC|June 10, 2010
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyMieke Van Hemelrijck, Hans Garmo, Elisa Binda, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2011
Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosisHenrik Møller, Fredrik Sandin, David Robinson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2017
Breast cancer in young women and prognosis: How important are proliferation markers?Hanna Fredholm, Kristina Magnusson, Linda S Lindström, et al.
Scandinavian Journal of Urology|March 8, 2021
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancerJohannes Bobjer, Oskar Hagberg, Firas Aljabery, et al.
BJUI Compass|May 7, 2025
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer: A nationwide population-based cohort studyChristel Häggström, Oskar Hagberg, Lars Holmberg, et al.
Pageof 29